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 Abstract: 
Background: The mortality and morbidity following aneurysmal subarachnoid hemorrhage 
(aSAH) has improved because of better diagnosis early treatment to secure the aneurysm, and 
better management of disease specific complications. With these improvements in care, it is 
not clear if the previously identified independent predictors of a negative outcome have 
changed. The aim of this study was to identify the independent predictors of an unfavorable 
outcome (Glasgow Outcome Score 1,2 & 3) in aSAH patients.  
Methods: Univariate and multivariate analysis of prospectively collected data on patients 
presenting with an aSAH was performed.  Outcome was assessed at discharge. Data were 
collected from 14 centers in the United Kingdom over a period of 4 years (September 2011-
2015). 
Results: The mean age (SD) at presentation of 3489 patients with aSAH was 55.3 (0.4). Most 
patients were female (n=2288 (68.5%), presented in good grade (2397 (70%)) (World 
Federation of Neurological surgeons (WFNS) grade 1&2), and were treated by endovascular 
coiling (n=2600) (75%). The independent predictors of an unfavorable outcome (95% CI) 
were increasing age (OR 1.04, (1.03-1.05) p<0.001), WFNS grade (OR  2.06 (1.91-2.22), 
p<0.001) pre-operative re-bleeding ( OR 7.41,(4.48-12.30) p<0.001) need for CSF diversion 
(OR 3.25, (2.58-4.09)p<0.001) and delayed cerebral ischemia (DCI) (OR 2.21, (1.72-2.83) 
p<0.001).  
Conclusion: These data suggest that potentially modifiable risk factors of pre-operative re-
bleeding and DCI are associated with unfavorable outcomes. Understanding the reasons why 
patients requiring CSF diversion have 3.25-fold higher adjusted odds of a poor outcome at 
discharge needs to be studied.  
 Introduction:  
Advances in diagnostic and treatment strategies for aSAH; through the introduction of CT 
angiography with early detection of aneurysms; the use of nimodipine; specialist care for 
patients; and endovascular coiling of ruptured aneurysms, has substantially improved the 
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on>}. Despite these improvements SAH continues to exact a high economic and social cost. 
It remains a disease of relatively young people (median age of presentation 52 years), and 
causes a loss of productive life-years similar to that of ischemic stroke.  Economically, the 
costs to the United Kingdom economy (in direct and indirect costs) are estimated to be GBP 
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 Although a number of factors have been identified as important in predicting outcome; poor 
presentation grade, increasing age, pre-protection aneurysm re-bleeding and delayed cerebral 
ischemia (DCI) are the only consistently identified independent predictors of a negative 
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on></publications><cites></cites></citation>}. Most of the studies used to determine 
prognostic factors to date are limited by either a) being single center series b) including a 
predominance of patients treated by open microneurosurgery, or c) using a selected patient 
group randomized to clinical trials. Although most analyze and report on large prospective 
patient datasets, these data have been accumulated over a long period of time, and given the 
improvements in outcome seen over the last decade(s) we do not know if the independent 
predictors of outcome reported are still valid. Equally, we do not know if there are any new 
prognostic factors that can be modified to drive further improvements in care and outcome.  
 
The aim of this study was to determine the independent predictors of a negative outcome in 
SAH patients from a contemporary dataset. 
Materials and Methods. 
The analysis was conducted on patients that presented with an aneurysmal SAH (aSAH).  
Patient records were identified from the UK and Ireland SAH audit database ({ HYPERLINK 
"http://www.hope-academic.org.uk/ukSAH/" }) a prospective collection of anonymized data 
from aSAH treated in UK neurosurgical centres from September 2011-2015. 
Demographic data (age, center, sex, presence of ischemic heart disease, hypertension, 
smoking status), severity of injury (WFNS (World Federation of Neurological Surgeons), 
aneurysm characteristics and treatments (aneurysm location, time to intervention, aneurysm 
treatment, need for CSF (cerebrospinal fluid) diversion, complications (CSF infection, re-
bleed, delayed cerebral ischaemia (DCI)). Outcome was determined according to the 
 Glasgow Outcome Scale (GOS) at discharge. Discharge destination and length of stay were 
also recorded.  
All data submitted was subject to the following pre agreed definitions in accordance with the 
standard operating policy of the database. CSF infection was defined as definite (if 
microbiologically proven) or probable (clinical signs and symptoms of CSF sepsis leading to 
clinician starting anti-microbial treatment). Presence of hypertension and ischaemic heart 
disease was determined from the past medical history provided by the patient or relatives on 
admission. WFNS grade was recorded at the time of referral to the neurosurgical center. DCI 
was defined as “The occurrence of focal neurological impairment (such as hemiparesis, 
aphasia, apraxia, hemianopia, or neglect), or a decrease of at least 2 points on the Glasgow 
Coma Scale (GCS) (either on the total score or on one of its individual components [eye, 
motor on either side, verbal]). This should not be apparent immediately after aneurysm 
occlusion, and cannot be attributed to other causes by means of clinical assessment, CT or 








on of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome 
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group.</title><institution>Department of Neurology, Academic Medical Center, Amsterdam, 
the Netherlands. 
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rstName>Yvo</firstName><middleNames>B W E 
M</middleNames><lastName>Roos</lastName></author></authors></publication></public
 ations><cites></cites></citation>}.  GOS was dichotomised into favorable outcome (GOS 
4&5) and unfavorable (GOS 1-3). 
Data entry including outcome assessment at discharge was done by neurovascular clinical 
specialist nurses.  
Statistical analysis was performed using Wizard 1.8.17. Univariate analysis was performed 
for all categories to determine significant differences between patients making a favorable 
recovery and those not. Categorical variables were assessed using the Chi-squared test. 
Distribution of  continuous data was tested using the Shapiro-Wilk test. The t-test was used 
for normally distributed data and Mann-Whitney or Kruskall-Wallis for data that was not 
normally distributed. Case mix adjustment using binary logistic regression was then 
performed to determine the odds of achieving a unfavorable outcome or being discharged 
home with variables identified to be significant on univariate analysis. Significance was 
defined as p<0.05. 
Results: 
Of 4634 patients recorded on the UK and Ireland database, 3341 patients were recorded to 
have an intracranial aneurysm and were eligible for this analysis. The median age at 
presentation of the cohort was 55 years of age, and the majority of patients were female. 
Although most patients presented in good grade, almost a quarter of patients (n=854 (24.9%)) 
presented in poor grade. Most patients had anterior circulation aneurysms, three quarters of 
patients were treated by endovascular coiling, and over 1/3 (n=1058 (34.2%)) of patients 
required some form of a CSF diversion procedure. CSF diversion was in the form of an 
external ventricular drain in the majority (809/1058 (83%)).  
The majority of patients (n=2385 (71.4%)) had made a favorable recovery discharge, and 
most, (n=1836 (54.4.%)) were discharged home directly from the neurosciences center after a 
median hospital stay of 15 days (see table 1). 
 Patients that had an unfavorable outcome at discharge were significantly older, more often 
presented in poor clinical grade, were more likely to be smokers, and have a history of 
hypertension and/or IHD at presentation. The incidence of re-bleed, need for CSF diversion 
and CSF infection were significantly higher in patients with an unfavorable outcome. (table 
2).  
The time interval between admission and securing of aneurysm was not significantly longer 
for patients in the favorable group compared to patients in the unfavorable group.  
Significant factors from the univariate analysis were entered into a multiple regression model 
to determine the independent predictors of an unfavorable outcome at discharge and the 
adjusted odds of getting home.  
Previously well accepted independent predictors of negative outcome such as age, WFNS 
grade, pre-operative re-bleed and lack of treatment were confirmed in this cohort. (see table 
3). Increasing age, worse grade at presentation, pre operative re-bleed, no treatment were also 
factors which significantly reduced the odds of being discharged home. 
The model also identified that patients that had a CSF diversion procedure were 3.25 fold 
more likely to have an unfavorable outcome independent of age, WFNS grade, pre operative 
re-bleed, no treatment.  The adjusted odds of being discharged home was also significantly 
lower in patients that had a CSF diversion procedure. The reason for this is not clear, but 
given that the adjusted odds of getting home were significantly lower (OR 0.31 CI 0.15-0.70, 
P=0.005) for patients that had a definite CSF infection suggests that CSF infection may be a 
key contributor. (Table 4).   
Discussion 
We have shown that increasing age, WFNS grade at presentation, preoperative re-bleed, and 
DCI remain independent predictors of an unfavorable outcome in patients presenting with 
aSAH. We have also observed that the need for CSF diversion is associated with a 3.25-fold 
 adjusted odds of an unfavorable outcome at discharge. This data is important as 
understanding why the need for CSF diversion increases the risk of a poor outcome is likely 
to drive further improvements in outcome after aSAH particularly as factors such as age or 
injury severity cannot be modified. Definite CSF infection is an independent negative 
predictor of being discharge home and is a likely cause of poor outcomes associated with 
CSF diversion.  
Pre operatively re-bleeding is a well accepted predictor of outcome in many studies and 

















lications><cites></cites></citation>}. Early treatment of ruptured aneurysm is now 
 considered the norm to reduce re-bleeding and this is reflected in this series where the median 
time to treat was one day.  Ultra early treatment strategies have been proposed by a number 
of SAH treating specialists although this has not been shown to be any better than a more 
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ublications><cites></cites></citation>} In trying to stop pre operative re-bleeding it remains 
important to understand the population in which it occurs. Whilst critical to avoid re-
hemorrhage in good grade patients, re-bleed in poor grade patients may be the result of a 
purposeful treatment strategy driven by the clinical presentation and acute pathophysiological 
 changes. Equally it has been shown in contemporary studies that most re-bleeds occur within 
6 hours of aneurysm rupture and given that in the majority of health care systems patients 
require transferring to specialist centers even if practical to deliver an ultra early intervention 
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Given the challenges of minimizing negative effects of re-bleeding and DCI alluded to 
earlier, understanding the reasons for this increased odds of a poor outcome in patients 
requiring a CSF diversion may lead to more immediate improvements in outcome in sSAH 
patients. Although our data is not detailed enough to investigate why CSF diversion is bad,  it 
does suggests that CSF infection may be a contributory factors as confirmed CSF infection 
significantly reduced the odds of being discharged home. 
There are a number of other reasons why CSF diversion may lead to a negative outcome. 
This may be directly as a result of aSAH related hydrocephalus causing raised intracranial 
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argument for this approach is based on observations that poor grade patients can improve 
clinical grade after drainage of CSF and achieve outcomes similar to those that present in 
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  &lt;style&gt; 
     *{margin:0;padding:0}html,code{font:15px/22px arial,sans-
serif}html{background:#fff;color:#222;padding:15px}body{margin:7% auto 0;max-
width:390px;min-height:180px;padding:30px 0 15px}* &gt; 
body{background:url(//www.google.com/images/errors/robot.png) 100% 5px no-
repeat;padding-right:205px}p{margin:11px 0 22px;overflow:hidden}ins{color:#777;text-
decoration:none}a img{border:0}@media screen and (max-
width:772px){body{background:none;margin-top:0;max-width:none;padding-
right:0}}#logo{background:url(//www.google.com/images/branding/googlelogo/1x/googlelo
go_color_150x54dp.png) no-repeat;margin-left:-5px}@media only screen and (min-
resolution:192dpi){#logo{background:url(//www.google.com/images/branding/googlelogo/2
x/googlelogo_color_150x54dp.png) no-repeat 0% 0%/100% 100%;-moz-border-
image:url(//www.google.com/images/branding/googlelogo/2x/googlelogo_color_150x54dp.p




  &lt;/style&gt; 
  &lt;a href=//www.google.com/&gt;&lt;span id=logo aria-
label=Google&gt;&lt;/span&gt;&lt;/a&gt; 
  &lt;p&gt;&lt;b&gt;404.&lt;/b&gt; &lt;ins&gt;That’s an error.&lt;/ins&gt; 
  &lt;p&gt;The requested URL &lt;code&gt;/maps/geo&lt;/code&gt; was not found on this 
server.  &lt;ins&gt;That’s all we know.&lt;/ins&gt; 
</location><institution>Department of Neurology, University Hospital Dijkzigt, Rotterdam, 
The 
Netherlands.</institution><number>2</number><subtype>400</subtype><endpage>194</e






ations><cites></cites></citation>}. These observations suggest that routine CSF drainage is 
not always necessary and decisions should be made on a case by case basis rather than 
according to a set protocol even for poor grade patients.  
Our data represent the largest contemporary aSAH patient database. The patient episodes 
have been accumulated over a short space of time from multiple centers in the United 
Kingdom. It is data reflective of current clinical practice where about one quarter of patients 
are in poor grade at presentation, and most patients are treated early and by endovascular 
coiling. Outcomes at discharge were not available in only 4% of patients and overall only 5% 
of our data was missing. Our study is limited in that the data from each center has not been 
independently validated, although data is collected by clinical nurse specialists that are well 
versed with the SAH patient journey, and collected according to pre set definitions. Only 4 
centers have provided data on consecutive patients over the 5 year period although once 
centers started contributing most (10/14) continued to submit data regularly. Our data is also 
limited in that outcomes are recorded at discharge whilst most clinical trials report outcomes 
at 3 months. 
Summary/Conclusions 
In a large contemporary series of aSAH we have shown that potentially modifiable risk 
factors of pre operative re-bleeding and DCI remain barriers to favorable outcomes. 
 Understanding the reasons why patients requiring CSF diversion have higher adjusted odds of 
a poor outcome at discharge needs to be studied further. 
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  Table 1: Overall demographics and outcomes in patients with aneurysmal SAH. 
Number of patients with intracranial 
aneurysms 
3341 
Median age (IQR) 55(18) 
sex (% Female) 68.5% 
Median time to treat (days) 1(2) 
WFNS                                               grade 1 1715 (49.7%) 
grade 2 682 (19.8%) 
grade 3 202 (5.8%) 
grade 4 412 (11.9%) 

















Hypertension 1155 (35.6%) 
Ischaemic Heart disease 222 (7%) 
Smoker 1398(45.2%) 
Pre operative re-bleed 133 (4.9%) 
Delayed Cerebral Ischaemia 681 (21.7%) 
CSF diversion 1058 (34.2%) 
CSF sepsis ( definate) 171(5.6%) 
LOS (IQR) 15 (14) 
GOS at discharge                   Favourable  
                                                 Unfavorable 
2385 (71.4%) 
956 (28.6%) 
Discharge destination     Home 
                                          District general  
                                          Rehabilitation 











Age (median)(IQR) 54 (17) 60 (19) p<0.001 
Sex (%Female) 1540 (67.7) 649 (70.2%) p=0.168 
Time to treat days (Median)(IQR) 






WFNS grade 1 1505(63.6%) 166 (17.5%) p<0.001 
WFNS grade 2 490 (20.7%) 160 (16.9%)  
WFNS grade 3 103 (4.4%) 85 (9%)  
WFNS grade 4 178((7.5%) 208 (21.9%)  
WFNS grade 5 91 (3.8%) 330 (34.8%)  
Hypertension 749 (32.7) 362 (44.1%) p<0.001 
Ischaemic Heart disease 135 (6%) 78 ( 10%) p<0.001 
Smoker 1040 (46.4%) 310 (42.6%) p=0.08 
Site of Aneurysm 
                   anterior  









          Endovascular 
          Surgical 
          Both 










149 ( 15.7%) 
p<0.001 







Delayed Cerebral Ischaemia (%)  














                                    definate 








Length of stay (median)(IQR) 14 (11) 22 (30) p<0.001 
Table 2: Baseline characteristics of patients that made a favorable recovery vs those that did 
not. 
  
Table 3: The adjusted odds of an unfavorable outcome. 
Explanatory variable Odds Ratio 95% CI p value 
Age 1.04 1.03-1.05 p<0.001 
WFNS grade 1.84 1.91-2.22 p<0.001 
Pre-op re-bleed 7.23 4.48-12.30 p<0.001 
DCI 2.23 1.72-2.83 p<0.001 
Hypertension 0.95 0.73-1.14 p=0.661 
IHD 1.02 0.65-1.40 p=0.954 
Treatment 0.20 0.64-1.08 p<0.001 
CSF diversion 3.52 2.58-4.09 p<0.001 
CSF infection 
                        definite 












Table 4: The adjusted odds of getting home 
Explanatory variable Odds Ratio 95% CI p value 
Age 0.95 0.94-0.96 p<0.001 
WFNS grade 0.44 0.40-0.47 p<0.001 
Pre-op re-bleed 0.18 0.11-0.32 p<0.001 
DCI 0.40 0.30-0.47 p<0.001 
Hypertension 1.24 0.92-1.43 p=0.661 
History of IHD 1.22 1.02-1.51 p=0.954 
Treatment 0.53 0.42-0.67 p<0.001 
CSF diversion 0.34 0.15-0.67 p<0.001 
CSF infection 
                        definite 
                        probable 
 
0.31 
0.78 
 
0.15-0.70 
0.39-1.54 
 
p=0.004 
p=0.473 
 
 
